Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 10:06 PM
Ignite Modification Date: 2025-12-24 @ 10:06 PM
NCT ID: NCT03204435
Eligibility Criteria: Inclusion Criteria: * For aneurysms: * with diagnosed complex intracranial aneurysm by digital subtraction angiography(DSA); * got SAH in history; * neural functional deficits due to aneurysms; * with \<4 in Hunt-Hess Grades; * ≥5.0mm in the maximum diameter; * \<70 years old; * with irregular morphological features and high rupture risk. and for stenosis * Intracranial vessels: * \>50% in rate of stenosis with ischemic symptoms/perfusing evidence/lacunar infarction in supplying territory, failed in conservative treatment; * with a deliverable position of intracranial stents devices. * or Vertebral arterial system: * ≥70% in the rate of stenosis, with contralateral vertebral arterial occlusion; * symptomatic vertebral arterial stenosis, accompanied with posterior inferior cerebellum artery derived from the affected artery and related symptoms are caused/clinical benefits can be achieved through angioplasty. * or Extracranial arterial system: * ≥70% in the rate of stenosis with symptoms; * nonsymptomatic patients, ≥70% in the rate of stenosis , with perfusing evidence. Exclusion Criteria: * \>70 in age, with low rupture risk; * stroke history in 6 weeks (contraindication for endovascular intervention); * coexistence with intracranial tumor or AVM; * cannot tolerant the operation; * patient or relative refuses to participate the trail
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 70 Years
Study: NCT03204435
Study Brief:
Protocol Section: NCT03204435